Study #2024-0149
An open label, multicenter rollover study for continued characterization of safety and tolerability of TT-00420 (tinengotinib) tablet monotherapy in adult patients with advanced solid tumors
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study is an open-label, multicenter study for Continued Characterization of Safety and Tolerability of TT-00420 (tinengotinib) Tablet Monotherapy in Adult Patients with Advanced Solid Tumors
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Advanced Solid Tumors;Cholangiocarcinoma
Study phase:
Physician name:
Sarina Piha-Paul
Department:
Investigational Cancer Therapeutics
For general questions about clinical trials:
1-844-635-1016
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.